1 |
Keceli G , Gupta A , Sourdon J , Gabr R , Schär M , Dey S , Tocchetti CG , Stuber A , Agrimi J , Zhang Y , Leppo M , Steenbergen C , Lai S , Yanek LR , O'Rourke B , Gerstenblith G , Bottomley PA , Wang Y , Paolocci N , Weiss RG . Mitochondrial creatine kinase attenuates pathologic remodeling in heart failure. Circ Res, 2022, 130: 741- 759.
|
2 |
Rahbani JF , Roesler A , Hussain MF , Samborska B , Dykstra CB , Tsai L , Jedrychowski MP , Vergnes L , Reue K , Spiegelman BM , Kazak L . Creatine kinase B controls futile creatine cycling in thermogenic fat. Nature, 2021, 590: 480- 485.
doi: 10.1038/s41586-021-03221-y
|
3 |
Shaikh S , Gonzalez - Zapata A , Mujeeb A , Rauf A , Thekkemuriyil D . Asymptomatic hyperCKemia: a diagnostic trap. Cureus, 2021, 13: e12791.
|
4 |
Shehata RS , Radwan NA , Bakry HM , Seif Eldin A . Assessment of serum CK - MM level as a bioindicator for work - related musculoskeletal injuries among emergency hospital workers. Toxicol Ind Health, 2022, 38: 11- 18.
doi: 10.1177/07482337211042727
|
5 |
Silvestri NJ , Wolfe GI . Asymptomatic/pauci - symptomatic creatine kinase elevations (hyperckemia). Muscle Nerve, 2013, 47: 805- 815.
doi: 10.1002/mus.23755
|
6 |
Nanji AA . Serum creatine kinase isoenzymes: a review. Muscle Nerve, 1983, 6: 83- 90.
doi: 10.1002/mus.880060203
|
7 |
Kyriakides T , Angelini C , Schaefer J , Sacconi S , Siciliano G , Vilchez JJ , Hilton-Jones D; European Federation of Neurological Societies . EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol, 2010, 17: 767- 773.
doi: 10.1111/j.1468-1331.2010.03012.x
|
8 |
Moghadam - Kia S , Oddis CV , Aggarwal R . Approach to asymptomatic creatine kinase elevation. Cleve Clin J Med, 2016, 83: 37- 42.
doi: 10.3949/ccjm.83a.14120
|
9 |
Choi SJ , Hong YH , Kim JS , Shin JY , Sung JJ . HyperCKemia in Guillain-Barré syndrome. Eur Neurol, 2020, 83: 415- 420.
doi: 10.1159/000508747
|
10 |
Hill J , Li J , Li Y . Incidence and influence of hyperCKemia in Legionella infection. J Neurol Sci, 2022, 436: 120252.
doi: 10.1016/j.jns.2022.120252
|
11 |
Finsterer J , Scorza FA , Scorza CA . Significance of asymptomatic hyper Creatine - Kinase emia. J Clin Neuromuscul Dis, 2019, 21: 90- 102.
doi: 10.1097/CND.0000000000000269
|
12 |
Gemelli C , Traverso M , Trevisan L , Fabbri S , Scarsi E , Carlini B , Prada V , Mongini T , Ruggiero L , Patrone S , Gallone S , Iodice R , Pisciotta L , Zara F , Origone P , Rota E , Minetti C , Bruno C , Schenone A , Mandich P , Fiorillo C , Grandis M . An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic hyperCKemia. Muscle Nerve, 2022, 65: 96- 104.
doi: 10.1002/mus.27448
|
13 |
Prelle A , Tancredi L , Sciacco M , Chiveri L , Comi GP , Battistel A , Bazzi P , Martinelli Boneschi F , Bagnardi V , Ciscato P , Bordoni A , Fortunato F , Strazzer S , Bresolin N , Scarlato G , Moggio M . Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. J Neurol, 2002, 249: 305- 311.
doi: 10.1007/s004150200010
|
14 |
Malandrini A , Orrico A , Gaudiano C , Gambelli S , Galli L , Berti G , Tegazzin V , Dotti MT , Federico A , Sorrentino V . Muscle biopsy and in vitro contracture test in subjects with idiopathic hyperCKemia. Anesthesiology, 2008, 109: 625- 628.
doi: 10.1097/ALN.0b013e3181862a0d
|
15 |
Dabby R , Sadeh M , Herman O , Berger E , Watemberg N , Hayek S , Jossiphov J , Nevo Y . Asymptomatic or minimally symptomatic hyperCKemia: histopathologic correlates. Isr Med Assoc J, 2006, 8: 110- 113.
|
16 |
Kokotis P , Papadimas GK , Zouvelou V , Zambelis T , Manta P , Karandreas N . Electrodiagnosis and muscle biopsy in asymptomatic hyperckemia. Int J Neurosci, 2016, 126: 514- 519.
|
17 |
Alcahut - Rodríguez C , Díaz - Maroto I , Fernández - Marmiesse A , García-García J . Paucisymptomatic hyperCKemia due to a mutation in the ANO5 gene. Neurologia (Engl Ed), 2020, 35: 510- 512.
|
18 |
Suthar R , Kesavan S , Sharawat IK , Malviya M , Sirari T , Sihag BK , Saini AG , Jyothi V , Sankhyan N . The expanding spectrum of dystrophinopathies: hyperCKemia to manifest female carriers. J Pediatr Neurosci, 2021, 16: 206- 211.
doi: 10.4103/jpn.JPN_89_20
|
19 |
Fernandez C , de Paula AM , Figarella - Branger D , Krahn M , Giorgi R , Chabrol B , Monfort MF , Pouget J , Pellissier JF . Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia. Neurology, 2006, 66: 1585- 1587.
doi: 10.1212/01.wnl.0000216144.69630.6e
|